population health

Research in Review

Antiandrogen Therapy Improves Survival After Prostate Cancer Recurrence

02/07/2017

JCP Editors

Radiation therapy plus bicalutamide improves long-term survival for men with recurring prostate cancer after initial surgery, according to a study published in the New England Journal of Medicine...

...

02/07/2017

Journal of Clinical Pathways

Research in Review

ADT Not Associated With Increased Risk of Dementia for Patients With Prostate Cancer

02/01/2017

JCP Editors

Treating advanced prostate cancer with androgen deprivation therapy (ADT) does not increase risk of Alzheimer’s disease, according to research published in the Journal of Clinical Oncology. ADT is prescribed to men...

...

02/01/2017

Journal of Clinical Pathways

Research in Review

Anxiety Increases Risk of Mortality for Patients With NSCLC

01/31/2017

JCP Editors

Patients with newly-diagnosed non-small cell lung cancer (NSCLC) who experience anxiety are at a higher risk of cancer-specific mortality, according to research published in the Journal of Pain and Symptom...

...

01/31/2017

Journal of Clinical Pathways

Research in Review

Cardiotoxicity Among Childhood Cancer Survivors Decreasing Over Time

01/24/2017

JCP Editors

Initiatives to reduce cardiotoxicity among childhood patients with cancer treated more recently have had a measurable impact over time, according to research published in Circulation. ----- Related Content Risk of...

...

01/24/2017

Journal of Clinical Pathways

Research in Review

Five-Tiered Gleason Grade Grouping System Accurately Predicts Prostate Cancer-Specific Mortality

01/20/2017

JCP Editors

A population-based study recently validated the five-tiered Gleason Grade Grouping system for predicting mortality among patients with prostate cancer, published in European Urology. Clinicians have used the Gleason...

A...

01/20/2017

Journal of Clinical Pathways

Research in Review

Decreased PSA Screening Leads to Higher Rates of Metastatic Prostate Cancer in Older Men

01/03/2017

JCP Editors

Increase in metastatic prostate cancer in older men has a definitive correlation with changes in prostate cancer screening guidelines recommending against prostate-specific antigen (PSA) testing, according to...

...

01/03/2017

Journal of Clinical Pathways

Research in Review

SBRT Efficacy May Depend on Lung Cancer Histologic Classification

12/28/2016

JCP Editors

Patients with early-stage non-small cell lung cancer (NSCLC) may be more or less responsive to stereotactic body radiation therapy (SBRT) based upon histological classification, according to a study published in the...

...

12/28/2016

Journal of Clinical Pathways

Research in Review

Ibuprofen May Lower Risk of Lung Cancer Death Among Smokers

12/21/2016

JCP Editors

Regular ibuprofen intake may lower the risk of lung cancer death among individuals with current or past histories of smoking, according to a new study. ----- Related Content New Lung Cancer Biomarker...

...

12/21/2016

Journal of Clinical Pathways

Research in Review

Few RCTs of New Systemic Therapies Met ESMO Guidelines for Meaningful Outcomes

12/13/2016

JCP Editors

Fewer than one-third of randomized controlled trials reporting statistically significant outcomes for novel systemic therapies in solid cancers met the European Society of Medical Oncology’s (ESMO) threshold for...

Fewer...

12/13/2016

Journal of Clinical Pathways

Research in Review

Stepped Care Program Targeting Psychological Distress Deemed Cost-Effective

12/09/2016

JCP Editors

A stepped care program has been deemed more cost-effective than care-as-usual in patients with head and neck cancer or lung cancer who have psychological distress, according to a recent study published in the Journal...

A...

12/09/2016

Journal of Clinical Pathways